RESUMO
BACKGROUND: Postural assessment is crucial as risk of falling is a major health problem for the elderly. The most widely used devices are force and balance plates, while center of pressure is the most studied parameter as measure of neuromuscular imbalances of the body sway. In out-of-laboratory conditions, where the use of plates is unattainable, the center of mass can serve as an alternative. This work proposes a center of mass-based posturographic measurement for free living applications. METHODS: Ten healthy and ten Parkinson's disease individuals (age = 26.1 ± 1.5, 70.4 ± 6.2 years, body mass index = 21.7 ± 2.2, 27.6 ± 2.8 kg/m2, respectively) participated in the study. A stereophotogrammetric system and a force plate were used to acquire the center of pressure and the 5th lumbar vertebra displacements during the Romberg test. The center of mass was estimated using anthropometric measures. Posturographic parameters were extracted from center of pressure, center of mass and 5th lumbar vertebra trajectories. Normalized root mean squared difference was used as metric to compare the trajectories; Spearman's correlation coefficient was computed among the posturographic parameters. FINDINGS: Low values of the metric indicated a good agreement between 5th lumbar vertebra trajectory and both center of pressure and center of mass trajectories. Statistically significant correlations were found among the postural variables. INTERPRETATION: A method to perform posturography tracking the movement of the 5th lumbar vertebra as an approximation of center of mass has been presented and validated. The method requires the solely kinematic tracking of one anatomical landmark with no need of plates for free living applications.
Assuntos
Doença de Parkinson , Equilíbrio Postural , Humanos , Idoso , Movimento , Fenômenos BiomecânicosRESUMO
BACKGROUND: Under water gait training (UT) has been proposed as an innovative rehabilitative strategy for the treatment of axial disorders in Parkinson Disease (PD) patients, in particular for balance and gait impairment. However, the basis for the improvement is unclear. RESEARCH QUESTION: The aim of this study was to evaluate improvements in the muscular activation in the lower limbs in a cohort of PD patients after UT. METHODS: Ten PD participants in the "off" state and 10 controls (mean ± standard deviation of age and BMI were respectively: 71 ± 6 years, 28 ± 3 kg/m2; 65.5 ± 7 years, 28 ± 3 kg/m2) were enrolled in the study. After signing informed consent, they walked barefoot at their preferred speed on a 10 m walkway, before and after UT. The electrical activity of four muscles were collected bilaterally by means of a surface electromyography system (sEMG), two force plates and a motion capture system. All signals were synchronized in time with the gait cycle. The sEMG activity of Rectus Femoris (RF), Tibialis Anterior (TA), Biceps Femoris (BF) and Gastrocnemius Lateralis (GL) were acquired. The average from each signal was used to extract the peak of the Envelope (PoE) and its occurrence with respect to the gait cycle (PoPE%). Time and space parameters were determined. RESULTS: Our results showed that UT in PD patients improved the muscle's recruitment pattern towards normal. The PD patients POPE% was comparable with the one of the controls (TA: 20-35 %, 75-80 % of gait cycle; GL: 0-15 %, 25-45 %, 85-100 % of gait cycle) after UT on each muscle with the exception of BF. The muscle co-activation plots failed to show improvement in line with the muscle activation. SIGNIFICANCE: These results suggest that the muscle activation improvement with UT in PD participants might be due to a reorganisation at the executive rather than at the command level.
Assuntos
Terapia por Exercício , Marcha/fisiologia , Extremidade Inferior/fisiologia , Músculo Esquelético/fisiologia , Doença de Parkinson/terapia , Idoso , Eletromiografia , Feminino , Humanos , Masculino , Projetos PilotoRESUMO
Plantar pressure simulation driven by integrated 3D motion capture data, using both a finite element and a discrete element model, is compared for ten healthy and ten diabetic neuropathic subjects. The simulated peak pressure deviated on average between 16.7 and 34.2% from the measured peak pressure. The error in the position of the peak pressure was on average smaller than 4.2 cm. No method was more accurate than the other although statistical differences were found between them. Both techniques are thus complementary and useful tools to better understand the alteration of diabetic foot biomechanics during gait.
Assuntos
Simulação por Computador , Diabetes Mellitus/fisiopatologia , Análise de Elementos Finitos , Pé/fisiopatologia , Pressão , Adulto , Fenômenos Biomecânicos , Estudos de Casos e Controles , Pé Diabético/fisiopatologia , Humanos , Pessoa de Meia-Idade , Reprodutibilidade dos TestesRESUMO
Psoralens are well-known photosensitizers, and 8-methoxypsoralen and 4,5',8-trimethylpsoralen are widely used in photomedicine as "psoralens plus UVA therapy" (PUVA), in photopheresis, and in sterilization of blood preparations. In an attempt to improve the therapeutic efficiency of PUVA therapy and photopheresis, four poly(ethylene glycol) (PEG)-psoralen conjugates were synthesized to promote tumor targeting by the enhanced permeability and retention (EPR) effect. Peptide linkers were used to exploit specific enzymatic cleavage by lysosomal proteases. A new psoralen, 4-hydroxymethyl-4',8-dimethylpsoralen (6), suitable for polymer conjugation was synthesized. The hydroxy group allowed exploring different strategies for PEG conjugation, and linkages with different stability such ester or urethanes were obtained. PEG (5 kDa) was covalently conjugated to the new psoralen derivative using four different linkages, namely, (i) direct ester bond (7), (ii) ester linkage with a peptide spacer (8), (iii) a carbamic linker (9), and (iv) a carbamic linker with a peptide spacer (12). The stability of these new conjugates was assessed at different pHs, in plasma and following incubation with cathepsin B. Conjugates 7 and 8 were rapidly hydrolyzed in plasma, while 9 was stable in buffer and in the presence of cathepsin B. As expected, only the conjugates containing the peptide linker released the drug in presence of cathepsin B. In vitro evaluation of the cytotoxic activity in the presence and absence of light was carried out in two cell lines (MCF-7 and A375 cells). Conjugates 7 and 8 displayed a similar activity to the free drug (probably due to the low stability of the ester linkage). Interestingly, the conjugates containing the carbamate linkage (9 and 12) were completely inactive in the dark (IC50 > 100 microM in both cell lines). However, antiproliferative activity become apparent after UV irradiation. Conjugate 12 appears to be the most promising for future in vivo evaluation, since it was relatively stable in plasma, which should allow tumor targeting and drug release to occur by cathepsin B-mediated hydrolysis.
Assuntos
Furocumarinas/química , Polietilenoglicóis/química , Linhagem Celular , Sobrevivência Celular , Furocumarinas/sangue , Humanos , Hidrólise , Teste de Materiais , Modelos Moleculares , Polietilenoglicóis/metabolismoRESUMO
The disposition of the furocoumarin 4,6,4'-trimethylangelicin (4,6,4'-TMA) was studied in mice. After oral administration of (3)H 4,6,4'-TMA, radioactivity measured in serum shows fast absorption and slow elimination. Serum protein binding is higher as compared to 8-methoxypsoralen (8-MOP), currently used in photochemotherapy (PUVA) and linearly declines from 30 min to 6 h after administration. Distribution in the various organs was similar to that of 8-MOP and was relatively uninfluenced by UVA radiation, required for the biological effects of 4,6,4'-TMA. Mice eliminate (3)H 4,6,4'-TMA mostly through the urine, but also through the faeces. Two metabolites were identified in the urine and serum of the treated mice, one of which proved to be a derivative of 4,6,4'-TMA, formed by hydrogenation of the double 4',5' bond of the furocoumarin nucleus.
Assuntos
Furocumarinas/farmacocinética , Terapia PUVA , Animais , Escuridão , Camundongos , Ligação Proteica , Distribuição Tecidual , Raios UltravioletaRESUMO
The antitumour agent 1-beta-D arabinofuranosilcytosyne (Ara-C) was covalently linked to poly(ethylene glycol) (PEG) in order to improve the in vivo stability and blood residence time. Eight PEG conjugates were synthesised, with linear or branched PEG of 5000, 10000 and 20000 Da molecular weight through an amino acid spacer. Starting from mPEG-OH or HO-PEG-OH, conjugation was carried out to the one or two available hydroxyl groups at the polymer's extreme. Furthermore, to increase the drug loading of the polymer, the hydroxyl functions of PEG were functionalised with a bicarboxylic amino acid yielding a tetrafunctional derivative and, by recursive conjugation with the same bicarboxylic amino acid, products with four or eight Ara-C molecules for each PEG chain were prepared. A computer graphic investigation demonstrated that aminoadipic acid was a suitable bicarboxylic amino acid to overcome the steric hindrance between the vicinal Ara-C molecules in the dendrimeric structure. In this paper we report the optimised conditions for synthesis and purification of PEG-Ara-C products with a low amount of remaining free drug, studies toward the hydrolysis of PEG-Ara-C and the Ara-C deamination by cytidine deaminase, pharmacokinetics in mice and cytotoxicity towards HeLa human cells were also investigated. Increased stability towards degradation of the conjugated Ara-C products, in particular for the highly loaded ones, improved blood residence time in mice and a reduced cytotoxicity with respect to the free Ara-C form was demonstrated.
Assuntos
Antineoplásicos/síntese química , Antineoplásicos/farmacocinética , Citarabina/síntese química , Citarabina/farmacocinética , Polietilenoglicóis/síntese química , Polietilenoglicóis/farmacocinética , Animais , Antineoplásicos/farmacologia , Morte Celular/efeitos dos fármacos , Citarabina/farmacologia , Citidina Desaminase/antagonistas & inibidores , Preparações de Ação Retardada/síntese química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Estabilidade de Medicamentos , Células HeLa , Humanos , Concentração de Íons de Hidrogênio , Camundongos , Estrutura Molecular , Peso Molecular , Polietilenoglicóis/farmacologia , Fatores de TempoRESUMO
A procedure for enzyme entrapment into matrices suitable for biocatalytic applications is reported. The method, which takes advantage of the stable formation of polyvinyl alcohol (PVA) hydrogels by freezing and thawing PVA aqueous solutions, was assayed using lipase as model enzyme. The leakage of lipase was minimised by using high molecular weight PVA and by previous conjugation of the enzyme to PEG. The immobilised PEG enzyme maintained its catalytic activity in organic solvents also, thus allowing enzymatic activity towards water insoluble substrates. The activity was largely increased reducing the diffusional constrain by cutting the matrices into slices of micron size. Matrix-entrapped lipase-PEG, when used in the hydrolysis of acetoxycoumarins, showed a conversion rate of about 10 times lower than the enzyme-PEG in the free form, and maintained regioselectivity when a diacetylated product was used as substrate.
Assuntos
Hidrogéis/síntese química , Lipase/química , Álcool de Polivinil/química , Hidrogéis/química , HidróliseRESUMO
We designed and synthesized the hybrid 6, prepared combining the minor groove binders distamycin A and pyrrolo [2,1-c][1,4] benzodiazepine (PBD) 4, related to the natural occurring anthramycin (2) and DC-81 (3). In this paper, the effects of the compound 6 on molecular interactions between DNA and transcription factor Sp1 were studied. The results obtained demonstrate that PBD-distamycin hybrid is a powerful inhibitor of Sp1/DNA interactions.
Assuntos
Antineoplásicos/farmacologia , Benzodiazepinonas/farmacologia , DNA de Neoplasias/efeitos dos fármacos , Distamicinas/farmacologia , Fator de Transcrição Sp1/antagonistas & inibidores , Animais , Antineoplásicos/química , Benzodiazepinonas/síntese química , Benzodiazepinonas/química , Linfoma de Burkitt/patologia , Divisão Celular/efeitos dos fármacos , DNA de Neoplasias/metabolismo , Distamicinas/síntese química , Distamicinas/química , Ensaios de Seleção de Medicamentos Antitumorais , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Células K562/efeitos dos fármacos , Leucemia L1210/patologia , Espectroscopia de Ressonância Magnética , Camundongos , Fator de Transcrição Sp1/metabolismo , Transcrição Gênica/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
Some photochemical and photobiological properties of 4,6,8,9-tetramethyl-2H-furo[2,3-h]quinolin-2-one (HFQ) were studied in comparison with its isomer 1,4,6,8-tetramethyl-2H-furo[2,3-h]quinolin-2-one (FQ) and 8-methoxypsoralen (8-MOP). The HFQ photobinds to DNA forming furan-side monoadducts (MAHFQ) that have molecular structure very similar to those of FQ (MAFQ). Unlike MA8-MOP and MAFQ, MAHFQ no longer photoreact. The HFQ, like FQ, produces moderate amounts of singlet oxygen but no superoxide anions. The HFQ and FQ induce numbers of DNA-protein cross-links (DPC), much more plentiful than those of 8-MOP (about two and seven times, respectively) but no interstrand cross-links. The mechanism of DPC formation was studied in vivo in mammalian cells by alkaline elution and in vitro using a new test mixing histones and DNA from calf thymus. The latter is a very useful technique for the double irradiation protocol. The DNA (or histones) are separately exposed to a first UVA dose in the presence of the sensitizer; then, after its unbound molecules have been removed, histones (or DNA) are added to assemble the chromatin-like complex that is irradiated again. According to in vitro and in vivo methods, DPC appear to be formed by FQ and 8-MOP by a biphotonic process that starts with monoadduct induction in DNA, followed by their conversion into DPC. In the resulting lesions, the sensitizer molecule forms a covalent bridge between the two macromolecules (DPC at length greater than zero). Instead, HFQ induces DPC by a monophotonic process; thus, HFQ is probably not a physical part of the bridge between DNA and proteins, which may be linked together directly, like DPC at zero length induced by UVC.
Assuntos
Dano ao DNA , Fármacos Fotossensibilizantes/toxicidade , Quinolonas/toxicidade , Animais , Bovinos , Técnicas In Vitro , Metoxaleno/toxicidade , Fotoquímica , Espécies Reativas de Oxigênio , Raios Ultravioleta/efeitos adversosRESUMO
A new furoquinolinone derivative, 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one (HPFQ, 4), was prepared, in which the nitrogen atom in position 1 carries a hydroxypropyl chain. The antiproliferative activity of HPFQ was studied in comparison with its analogue 1,4,6,8-tetramethylfuro[2,3-h]quinolin-2(1H)-one (FQ) and 8-methoxypsoralen (8-MOP). By incubation in the dark, HPFQ, although retaining antitopoisomerase II activity, appeared less effective than FQ. Upon UVA irradiation, HPFQ produced little amounts of singlet oxygen, but detectable levels of superoxide anion; like FQ, HPFQ induced numbers of DNA-protein cross-links, but no interstrand cross-links in mammalian cells. The HPFQ phototoxicity was comparable to that of FQ and 8-MOP, while mutagenic activity, scored in two Escherichia coli strains, seemed much less remarkable.
Assuntos
Inibidores Enzimáticos/farmacologia , Furocumarinas/farmacologia , Mutagênicos/farmacologia , Fármacos Fotossensibilizantes/farmacologia , Inibidores da Topoisomerase II , Divisão Celular/efeitos dos fármacos , Dano ao DNA , Inibidores Enzimáticos/química , Furocumarinas/química , Células HeLa , Humanos , Estrutura Molecular , Mutagênicos/química , Fotobiologia , Fármacos Fotossensibilizantes/químicaRESUMO
The synthesis, biological activity, and DNA-binding properties of a series of four hybrids prepared by combining polypyrrole minor groove binders and pyrrolo[2,1-c][1,4]benzodiazepine (PBD) 13, related to the naturally occurring anthramycin (3) and DC-81 (4), have been described, and structure-activity relationships have been discussed. These hybrids 22-25 contain from one to four pyrrole units, respectively. To investigate sequence selectivity and stability of drug/DNA complexes, DNase I footprinting and arrested polymerase chain reaction (PCR) were performed on human c-myc oncogene, estrogen receptor gene, and human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR) gene sequences. The antiproliferative activity of the hybrids has been tested in vitro on human myeloid leukemia K562 and T-lymphoid Jurkat cell lines and compared to antiproliferative effects of the natural product distamycin A 1, its tetrapyrrole homologue 17, DC 81 (4), and the PBD methyl ester 12. The results obtained demonstrate that the hybrids 22-25 exhibit different DNA-binding activity with respect to both distamycin A 1 and PBD 12. In addition, a direct relationship was found between number of pyrrole rings present in the hybrids 22-25 and stability of drug/DNA complexes. With respect to antiproliferative effects, it was found that the increase in the length of the polypyrrole backbone leads to an increase of in vitro antiproliferative effects, i.e., the hybrid 25 containing the four pyrroles is more active than 22, 23, and 24 both against K562 and Jurkat cell lines.
Assuntos
Antineoplásicos/farmacologia , Benzodiazepinonas/química , Divisão Celular/efeitos dos fármacos , DNA/metabolismo , Pirróis/química , Antineoplásicos/química , Antineoplásicos/metabolismo , Sequência de Bases , Benzodiazepinonas/metabolismo , Benzodiazepinonas/farmacologia , Pegada de DNA , Ensaios de Seleção de Medicamentos Antitumorais , Repetição Terminal Longa de HIV , Humanos , Células Jurkat , Células K562 , Reação em Cadeia da Polimerase , Pirróis/metabolismo , Pirróis/farmacologia , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/genética , Análise Espectral , Relação Estrutura-AtividadeRESUMO
Three derivatives of 1H,5H and 3H,5H-benzo[ij]quinolizin-5-one (BQZ1), previously prepared by chemical synthesis with the aim of obtaining furocoumarin analogs, have been studied. These are able to intercalate inside DNA and by subsequent irradiation with UVA light, to photoreact with DNA. Compound I (10-methoxy-7-methyl-1H,5H-benzo[ij]quinolizin-5-one) has a potentially photoreactive 2,3 double bond because of its conjugation with the pyridine ring of quinolinone, while compounds II (10-acetoxy-7-methyl-3H,5H-benzo[ij]quinolizin-5-one) and III (10-methoxy-7-methyl-3H,5H-benzo[ij]quinolizin-5-one) have a potentially photoreactive 1,2 double bond conjugated with the benzene ring of quinolinone. Compounds I and III, having a tricyclic planar structure, intercalate inside the DNA, while compound II cannot intercalate efficiently because of the steric hindrance of the acetoxy group in 10, lying outside the plane of the molecule and rotated by an angle of 77.6 degrees with respect to the tricyclic plane. The photoreaction of BQZ with DNA structure, as already known for psoralen and angelicin derivatives, consists of a [2 + 2] photocycloaddition reaction with the pyrimidine bases. The main photoadduct between the 2,3 double bond of I and the 5,6 double bond of thymine has been isolated and characterized by NMR, showing a cis-anti structure. Theoretical calculations, using AM1 Hamiltonian, have been carried out to describe the photocycloaddition reaction mechanism better. From a theoretical point of view, in the case of BQZ both the 1,2 or 2,3 double bonds and the 6,7 double bond may be involved in the [2 + 2] photocycloaddition. Spin densities and molecular orbital symmetries of compound I, in its triplet state, suggest that the 2,3 double bond interacts favorably with the 5,6 double bond of thymine moiety. On the contrary, the acetoxy substituent in position 10 of II seems to play a negative role in the DNA intercalation process.
Assuntos
Cumarínicos/síntese química , DNA/efeitos dos fármacos , Substâncias Intercalantes/síntese química , Quinolizinas/síntese química , Dicroísmo Circular , Cumarínicos/farmacologia , Reagentes de Ligações Cruzadas , DNA/efeitos da radiação , Adutos de DNA/efeitos dos fármacos , Adutos de DNA/efeitos da radiação , Fluorometria , Substâncias Intercalantes/farmacologia , Cinética , Modelos Moleculares , Teoria Quântica , Quinolizinas/farmacologia , Raios UltravioletaRESUMO
Some benzopsoralens, carrying a hydroxymethyl or a diethylaminomethyl group at the 3, 5, 8, and 11 positions, were prepared, and their biological activity was compared with that of 4-(hydroxymethyl)benzopsoralen (BP). 5-(Hydroxymethyl)benzopsoralen (7b), 11-(hydroxymethyl)benzopsoralen (7c), and 11-(diethylaminomethyl)benzopsoralen (8c) induced marked antiproliferative effects in mammalian cells by simple incubation in the dark; this activity appeared to be related to their ability to inhibit topoisomerase II. Benzopsoralens appeared to be more active, especially BP and 7c, upon UVA activation. Compounds carrying a methyl group at the 4 position together with a hydroxymethyl or diethylaminomethyl at the 8 position (7d and 8d, respectively) were also effective, although to a lower extent; instead, a substituent at the 3 position canceled all activity. Benzopsoralens did not induce interstrand cross-links in DNA in vitro, as seen in the induction of cytoplasmic <
Assuntos
Inibidores Enzimáticos/síntese química , Furocumarinas/síntese química , Fármacos Fotossensibilizantes/síntese química , Animais , Antineoplásicos/síntese química , Antineoplásicos/química , Antineoplásicos/farmacologia , Reagentes de Ligações Cruzadas/síntese química , Reagentes de Ligações Cruzadas/química , Reagentes de Ligações Cruzadas/farmacologia , DNA/química , DNA/efeitos da radiação , Dano ao DNA/efeitos dos fármacos , DNA Fúngico/efeitos dos fármacos , DNA Fúngico/efeitos da radiação , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Furocumarinas/química , Furocumarinas/farmacologia , Cobaias , Humanos , Técnicas In Vitro , Metoxaleno/química , Metoxaleno/farmacologia , Testes de Mutagenicidade , Mutação , Fármacos Fotossensibilizantes/química , Fármacos Fotossensibilizantes/farmacologia , Pele/efeitos da radiação , Espectrofotometria Ultravioleta , Relação Estrutura-Atividade , Inibidores da Topoisomerase II , Células Tumorais Cultivadas , Raios Ultravioleta , Leveduras/efeitos dos fármacos , Leveduras/genética , Leveduras/efeitos da radiaçãoRESUMO
Several A-ring-modified analogues of the DNA-binding antitumor agent DC-81 (5) have been synthesized in order to study structure-reactivity/cytotoxicity relationships. For two molecules (23 and 30) the modifications required the addition of a fourth ring to give the novel dioxolo[4,5-h]- and dioxano[5,6-h]pyrrolo[2,1-c][1, 4]benzodiazepin-11-one (PBD) ring systems, respectively. Another three analogues (34, 38, and 48) have the native benzenoid A-ring replaced with pyridine, diazine, or pyrimidine rings to give the novel pyrrolo[2,1-c][1,4]pyridodiazepine, pyrrolo[2,1-c][1, 4]diazinodiazepine, and pyrrolo[2,1-c][1,4]pyrimidinodiazepine systems, respectively. The other new analogues (16a,b) have extended chains at the C8-position of the DC-81 structure. During the synthesis of these compounds, a novel tin-mediated regiospecific cleavage reaction of the dioxole intermediate 18 was discovered, leading to the previously unknown iso-DC-81 (20). In addition, an unusual simultaneous nitration-oxidation reaction of 4-(3-hydroxypropoxy)-3-methoxybenzoic acid (8) was found to produce 3-(4-carboxy-2-methoxy-5-nitrophenoxy)propanoic acid (9), a key intermediate, in high yield. In general, the results of cytotoxicity and DNA-binding studies indicated that none of the changes made to the A-ring of the PBD system significantly improved either binding affinity or cytotoxicity in comparison to DC-81. This result suggests that the superior potency of natural products such as anthramycin (1), tomaymycin (2), and sibiromycin (3) is due entirely to differences in C-ring structure, and in particular exo or endo unsaturation at the C2-position and C2-substituents containing unsaturation. This study also provided information regarding the influence of A-ring substitution pattern on the relative stability of the interconvertible N10-C11 carbinolamine, carbinolamine methyl ether, and imine forms of PBDs.
Assuntos
Antineoplásicos/síntese química , Benzodiazepinas/síntese química , DNA/química , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Benzodiazepinas/química , Benzodiazepinas/farmacologia , Bovinos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Concentração Inibidora 50 , Camundongos , Desnaturação de Ácido Nucleico , Relação Estrutura-Atividade , Células Tumorais CultivadasRESUMO
DNA minor-groove binding drugs have been extensively studied in the last years in order to influence the regulation of gene expression in neoplastic disorders by means of specific interactions with DNA bases. Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs), CC-1065 and distamycins are three classes of minor-groove alkylating agents which showed interesting cytotoxicity profiles, but they cannot be used in humans for various toxicity problems. For this reason many groups applied heterocyclic substitutions extensively, in order to either modify the reactivity profile or introduce extra interactions within the minor groove, thus changing the binding site or modulating the binding sequence.
Assuntos
Antineoplásicos/metabolismo , Antineoplásicos/farmacologia , DNA de Neoplasias/efeitos dos fármacos , DNA de Neoplasias/metabolismo , Animais , Antineoplásicos/síntese química , Sítios de Ligação , HumanosRESUMO
It is generally accepted that neoplastic transformation is related to genes alteration or oncogene activation. In particular, DNA minor groove binding drugs have been extensively studied through the years in order to influence the regulation of gene expression by means of specific interactions with DNA bases moieties. Pyrrolo[2,1-c],[1,4].benzodiazepines (PBDs), CC-1065 and distamycins are three classes of minor groove binders which showed interesting cytotoxicity profiles, refined through already reviewed processes of SAR studies. Among the modifications to the three families of antitumor compounds, heterocyclic substitutions have been extensively applied by many groups in order to either modify the reactivity profile or introduce extra interactions within the minor groove, thus changing the binding site or modulating the binding sequence. The updated material related to these modifications has been rationalised and ordered to offer an overview of the argument.
Assuntos
Alquilantes/química , Antramicina/análogos & derivados , Antineoplásicos/química , Desenho de Fármacos , Compostos Heterocíclicos com 3 Anéis/química , Alquilantes/metabolismo , Alquilantes/farmacologia , Antramicina/química , Antramicina/farmacologia , Antineoplásicos/metabolismo , Antineoplásicos/farmacologia , Sítios de Ligação , Química Farmacêutica , Adutos de DNA , Compostos Heterocíclicos com 3 Anéis/metabolismo , Compostos Heterocíclicos com 3 Anéis/farmacologia , Estrutura Molecular , Relação Estrutura-AtividadeRESUMO
Novel C7-aryl pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) have been synthesized via Suzuki coupling between a 7-Iodo N10-Troc-protected PBD carbinolamine and commercially available boronic acids.
Assuntos
Antibióticos Antineoplásicos/síntese química , Benzodiazepinas/síntese química , Antibióticos Antineoplásicos/farmacologia , Benzodiazepinas/farmacologia , Humanos , Relação Estrutura-Atividade , Células Tumorais CultivadasRESUMO
We report the synthesis of a new hybrid 13 which is a combination of the naturally occurring antitumor agent distamycin A 1 and the pyrrolo[2,1-c][1,4]benzodiazepine 11, related to the naturally occurring anthramycin 2. The antitumor activity of the hybrid 13 was tested in vitro and compared to the natural product distamycin 1 and the PBD 11.
Assuntos
Antineoplásicos/síntese química , Benzodiazepinas/síntese química , Distamicinas/síntese química , Desenho de Fármacos , Antineoplásicos/metabolismo , Antineoplásicos/farmacologia , Benzodiazepinas/metabolismo , Benzodiazepinas/farmacologia , DNA/metabolismo , Distamicinas/metabolismo , Distamicinas/farmacologia , Humanos , Células K562 , Reação em Cadeia da PolimeraseRESUMO
1,4,6,8-Tetramethyl-2H-furo[2,3-h]quinolin-2-one [FQ] is an angelicin isoster characterized by a strong photosensitizing activity FQ shows a significant antiproliferative activity also in the dark, i.e., without UVA activation. The cytotoxic activity of FQ in the dark was detected in HeLa cells and in normal human lymphocytes; FQ showed notable antiproliferative effects, barely lower in comparison with ellipticine, used as a reference Similar results were obtained studying the FQ's capacity for forming chromosome aberrations. For both FQ and ellipticine, the chromosomal damage correlated closely with cell killing, when compared with ellipticine at the same levels of survival, FQ appeared to be much less genotoxic. Using alkaline elution we have investigated the ability of FQ to damage DNA. The formation of equivalent amounts of single-strand breaks (SSB) and DNA-protein cross-links (DPC) was observed; in addition, these lesions appeared to be located at the same sites in DNA. Experiments carried out with neutral elution demonstrated the formation of double-strand breaks (DSB). All these data are consistent with an inhibition of topoisomerase II; this hypothesis was confirmed performing an enzymatic test in vitro using topoisomerase II from Drosophila melanogaster embryos.
Assuntos
Sobrevivência Celular/efeitos dos fármacos , Dano ao DNA , Inibidores Enzimáticos/toxicidade , Fármacos Fotossensibilizantes/toxicidade , Quinolonas/toxicidade , Células HeLa , Humanos , Inibidores da Topoisomerase IIRESUMO
The synthesis of 2H-benzopyrano[7,8-b][1,4]tetrahydrobenzodioxin-2-ones and 2H-benzopyrano [7,8-b][1,4]benzodioxin-2-ones is reported. This class of compounds, prepared with the aim of obtaining new monofunctional photosensitizing drug, appears to be ineffective upon UVA irradiation but shows a moderate but significant activity in the dark.